Financing, Equity Capital Markets

Capricor Therapeutics, Inc.

10/24
|
$75.0 Million
capricor
Piper Sandler served as bookrunner for Capricor Therapeutics, Inc. on its CMFO
Sub-Type
CMFO
Sub-Sector
Biopharma